| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063676 Asthma symptomatic relief; formoterol and budesonide |
| 04/01/2004 | US20040063674 Tetracycline compounds having target therapeutic activities |
| 04/01/2004 | US20040063672 Method for the treatment of polycystic kidney disease |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063670 Use of bisphosphonates for pain treatment |
| 04/01/2004 | US20040063668 Antiviral agent; hepatitis B; such as ((1-((6-amino-9H-purin-9-yl)methyl)cyclopropyl)oxy)methylphosphonic acid |
| 04/01/2004 | US20040063667 Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phospate as active ingredient |
| 04/01/2004 | US20040063666 Compositions for inhibiting arginase activity |
| 04/01/2004 | US20040063665 Anticancer agents; high degree of discrimination toward malignant cells; reducing side effects; nontoxic; such as 3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one |
| 04/01/2004 | US20040063664 Simethicone containing tablet composition and method |
| 04/01/2004 | US20040063663 Acylated cyclodextrin: guest molecule inclusion complexes |
| 04/01/2004 | US20040063661 Treatment of statin side effects |
| 04/01/2004 | US20040063660 Increasing concentration in tissue and blood |
| 04/01/2004 | US20040063659 Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 04/01/2004 | US20040063658 Such as 9-(2'-C-methyl-beta-D-ribofuranosyl)-6-bromopurine |
| 04/01/2004 | US20040063655 Antisense modulation of transforming growth factor-beta expression |
| 04/01/2004 | US20040063651 3'-deoxy-3'-fluorouridine and 1-(3'-deoxy-fluoro-beta-ribofuranosyl)-uracil derivatives; reduced side effects; selectively inhibits viral RNA dependent RNA polymerase |
| 04/01/2004 | US20040063649 Azithromycin combination for emesis control in mammals |
| 04/01/2004 | US20040063648 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
| 04/01/2004 | US20040063646 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063641 Healing fractures in distractive osteogenesis; accelerating regeneration and consolidation; torsional and mechanical stiffness; mass |
| 04/01/2004 | US20040063636 Use of compounds for the regulation of food intake |
| 04/01/2004 | US20040063624 Method of inhibiting the transition of free HIV virus through the cllular mucosal barrier |
| 04/01/2004 | US20040063623 Formulation of boronic acid compounds |
| 04/01/2004 | US20040063622 Methods and compositions for treating flaviviruses and pestiviruses |
| 04/01/2004 | US20040063620 Compositions with enhanced antimicrobial efficacy against E. Coli |
| 04/01/2004 | US20040063612 For therapy of neurodegenerative diseases |
| 04/01/2004 | US20040063611 Comprising levothyroxine sodium, gelatine and fillers, which is free of organic solvent residues |
| 04/01/2004 | US20040063610 For therapy of mammal having a transected peripheral nerve or injured spinal cord |
| 04/01/2004 | US20040063607 Process to improve stability of a pharmaceutical composition |
| 04/01/2004 | US20040063178 Comprises enzymatic polypeptide for identifying modulators of leukocyte adhesion and treatments of inflammatory diseases l |
| 04/01/2004 | US20040063156 Materials and methods relating to the diagnosis and treatment of diabetes and obesity |
| 04/01/2004 | US20040062848 Lapactic agent |
| 04/01/2004 | US20040062847 Oil/fat composition |
| 04/01/2004 | US20040062844 Adduct of amino acid and artificial sweetener |
| 04/01/2004 | US20040062825 Remedies for allergic diseases and process for producing the same |
| 04/01/2004 | US20040062824 Composition for treating chronic venous insufficiencies using an extract of red vine leaves |
| 04/01/2004 | US20040062821 Administration of therapeutic compositions for treating fatigue |
| 04/01/2004 | US20040062820 Administering blend of calcium compound and fat; reducing osteoporosis |
| 04/01/2004 | US20040062819 Insertion catheter into cerebrospinal fluid; administering drug |
| 04/01/2004 | US20040062812 Drug in mixture of matrix forming polymer and ion exchange resin |
| 04/01/2004 | US20040062810 Removal blockage in blood vessels; mixture of angiogenesis inhibitor and polymer |
| 04/01/2004 | US20040062805 Pregelatinized starch in a controlled release formulation |
| 04/01/2004 | US20040062804 Multilayer; active materials, core, shell |
| 04/01/2004 | US20040062803 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 04/01/2004 | US20040062802 Maximizing effectiveness of substances used to improve health and well being |
| 04/01/2004 | US20040062801 Drug delivery device containing neuraminidase inhibitor and an H1 antagonist |
| 04/01/2004 | US20040062800 Compressed matrix tablet; mixture of drug and swellable polymer; side effect reduction |
| 04/01/2004 | US20040062794 Flexible backing; adhesive coating; transdermal supplying; reducing triglyceride concentration; sustained release |
| 04/01/2004 | US20040062790 Reabsorptable polyoxyethylene glycol; biodegradation, biocompatibility |
| 04/01/2004 | US20040062781 Retinol derivatives and process for preparing same |
| 04/01/2004 | US20040062779 Fine particle sizes; mixture of ascoric acid in stabilization, anhydrous vehicle; transdermal penetration |
| 04/01/2004 | US20040062773 Compositions for the delivery of antigens |
| 04/01/2004 | US20040062766 Cell separation compositions and methods |
| 04/01/2004 | US20040062764 Side effect reduction; anticancer agents, antitumor agents; administering mixture of cytotoxic agent and thiol compound into arteries |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062758 Immunostimulant; mixture of lactobacillus, propionibacterium, bifidobacterium |
| 04/01/2004 | US20040062757 Method of testing gastrointestinal diseases associated with species of genus clostridium |
| 04/01/2004 | US20040062754 Photopheresis treatment of chronic HCV infections |
| 04/01/2004 | US20040062745 Removal toxins; gastrointestinal disorders; anticholesterol agents |
| 04/01/2004 | US20040062744 Mixture of microbiocide and cationic polymer |
| 04/01/2004 | US20040062743 Mixture with film forming polymer |
| 04/01/2004 | US20040062736 Hair growth promoter |
| 04/01/2004 | US20040062724 Thin, flexible, multilayer film; applying, adhesion to teeth; supplying active materials |
| 04/01/2004 | US20040062721 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
| 04/01/2004 | US20040062719 Carrier for drug delivery; crystal structure core with surface coating; induce crystallization of amorphous particles; hermetic sealed packages |
| 04/01/2004 | US20040062718 Particles for inhalation having sustained release properties |
| 04/01/2004 | US20040062716 Aerosol; high speed absorption; mixture of solvent and active materials |
| 04/01/2004 | US20040061142 Treatment of skin conditions |
| 04/01/2004 | US20040061039 Furnace mount and method of installation |
| 04/01/2004 | US20040060865 Buffered compositions for dialysis |
| 04/01/2004 | US20040060568 Hedgehog antagonists, methods and uses related thereto |
| 04/01/2004 | DE202004000552U1 Mittel zum Bleichen von Zähnen Means for bleaching teeth |
| 04/01/2004 | DE10244453A1 Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten Inhibition of protein kinase C-alpha for the treatment of diseases |
| 04/01/2004 | DE10244397A1 Cholinascorbat-Formulierungen Choline formulations |
| 04/01/2004 | DE10244282A1 Zubereitung mit antioxidanten Eigenschaften Composition having antioxidant properties |
| 04/01/2004 | DE10243626A1 Haarbehandlungsmittel enthaltend eine Wirkstoffkombination mit Liposomen Hair treatment composition comprising an active ingredient combination with liposomes |
| 04/01/2004 | CA2768674A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | CA2539567A1 Nutritional and therapeutic compositions to increase bodily glutathione levels |
| 04/01/2004 | CA2535769A1 Polymer-linker-drug conjugates for targeted drug delivery |
| 04/01/2004 | CA2500367A1 Agents for protection from neointimal formation in grafts comprising an nfkb dekoy |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499897A1 Use of posaconazole for the treatment of fungal infections |
| 04/01/2004 | CA2499859A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 04/01/2004 | CA2499628A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug |
| 04/01/2004 | CA2499602A1 Skin photoageing and actinic damage treatment |
| 04/01/2004 | CA2499601A1 Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease |
| 04/01/2004 | CA2499599A1 Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors |
| 04/01/2004 | CA2499484A1 Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases |
| 04/01/2004 | CA2499390A1 Kits and methods for assessing skin health |
| 04/01/2004 | CA2499368A1 Compositions and methods for treating heart disease |
| 04/01/2004 | CA2499332A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2499265A1 Inhibitor of hepatitis c viruses comprising, as the active ingredient, alpha-glycosylceramide |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | CA2499200A1 Use of compounds in the treatment of dyskinesia |
| 04/01/2004 | CA2499199A1 Leucine-enriched nutritional compositions |
| 04/01/2004 | CA2499150A1 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |